Human FGF basic Quantikine HS ELISA Kit

(16 citations)   
  • Assay Length
    5.5 hours
  • Sample Type & Volume Required Per Well
    Serum (100 uL), EDTA Plasma (100 uL), Citrate Plasma (100 uL), Urine (100 uL)
  • Sensitivity
    0.07 pg/mL
  • Assay Range
    0.3 - 20 pg/mL (Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma, Urine)
  • Specificity
    Natural and recombinant human FGF basic
  • Cross-reactivity
    < 0.5% cross-reactivity observed with available related molecules.Cross-species reactivity not tested.
  • Interference
    No significant interference observed with available related molecules.
Product Summary
The Quantikine HS Human FGF basic Immunoassay kit is a 5.5 hour solid phase ELISA designed to measure FGF basic levels in serum, plasma, and urine. It contains E. coli-expressed recombinant human FGF basic and antibodies raised against the recombinant factor. It has been shown to quantitate recombinant human FGF basic accurately. Results obtained using natural human FGF basic showed linear curves that were parallel to the standard curves obtained using the Quantikine HS kit standards. These results indicate that this kit can be used to determine relative mass values for natural human FGF basic.

Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision.
Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma, Urine
Intra-Assay Precision Inter-Assay Precision
Standard Deviation0.


The recovery of FGF basic spiked to three different levels throughout the range of the assay in various matrices was evaluated.

Sample Type Average % Recovery Range %
Citrate Plasma (n=4) 97 83-118
EDTA Plasma (n=4) 99 85-109
Serum (n=4) 100 88-116
Urine (n=4) 109 100-120
To assess the linearity of the assay, the following biological samples spiked with high concentrations of FGF basic were diluted with Calibrator Diluent and assayed.
Human FGF basic Quantikine HS ELISA Kit
Preparation and Storage
  • Storage
    Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Background: FGF basic
FGF basic (FGF-2) is a growth factor that functions in angiogenesis, wound healing, tissue repair, learning and memory, and the morphogenesis of heart, bone, and brain. It is upregulated in response to inflammatory stimuli and in many tumors. FGF basic binds to FGF R1c and 2c. Its bioactivity is modulated by a number of other binding partners including heparin, Integrin alpha V beta 3, soluble FGF R1, FGF-BP, free gangliosides, Thrombospondin, Pentraxin 3/TSG-14, Fibrinogen, alpha 2-Macroglobulin, PDGF, and CXCL4/PF4. These molecules act as cellular coreceptors or adhesion partners, extracellular matrix decoys or reservoirs, and soluble scavengers or chaperones. In particular, the interaction of FGF basic with cell surface heparan sulfate proteoglycans (HSPG) is required for the binding and activation of FGF receptors.
    • Long Name
      Fibroblast Growth Factor basic
    • Entrez Gene IDs
      2247 (Human); 14173 (Mouse); 281161 (Bovine); 403857 (Canine); 100033955 (Equine);
    • Alternate Names
      basic fibroblast growth factor bFGF; Basic fibroblast growth factor; bFGF; FGF2; FGF-2; FGF2AS; FGFBprostatropin; fibroblast growth factor 2 (basic); GFG1; HBGF-2; HBGH-2; heparin-binding growth factor 2; NUDT6; Prostatropin;
    Related Research Areas

    R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

    Showing Results 1 - 10 of 16
    Filter your results:

    Sample Type
    1. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.
      Authors: Briasoulis, Evangelo, Aravantinos, Gerasimo, Kouvatseas, George, Pappas, Periklis, Biziota, Eirini, Sainis, Ioannis, Makatsoris, Thomas, Varthalitis, Ioannis, Xanthakis, Ioannis, Vassias, Antonios, Klouvas, George, Boukovinas, Ioannis, Fountzilas, George, Syrigos, Kostanti, Kalofonos, Haralamb, Samantas, Epaminon
      BMC Cancer, 2013;13(1):263.
      Species: Human
      Sample Type: Plasma
    2. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.
      Authors: Llovet JM, Pena CE, Lathia CD, Shan M, Meinhardt G, Bruix J, Pallota MG, Zarba JJ, Boyer M, Riordan S, Strickland A, Tebbutt N, Thomson B, Borbath I, De Greve J, Van Laethem J-, Van Steenbergen W, Van Vlierberghe H, Barrios C, Cosme de Oliveira A, Kotzev I, Takov D, Tchernev K, Burak K, Ma M, Metrakos P, Olweny C, Sherman M, Gamargo Garate C, Martinez-Castillo J, Beaugrand M, Bennouna J, Blanc J-, Bronowicki J-, Degos F, Dominguez S, Grange J-, Hillon P, Raoul J-, Seitz J-, Blum H, Buggisch P, Caspary W, Dollinger M, Gerken G, Goke B, Gregor M, Greten T, Haussinger D, Hilgard P, Scherübl J, Scheulen M, Schmid R, Spengler U, Wiest R, Zeuzem S, Arvanitakis C, Germanidis G, Katsos I, Figer A, Stemmer S, Amadori D, Bolondi L, Cognetti F, Craxi A, Farinati F, Gridelli C, Martoni A, Mazzaferro V, Porta C, Ricci S, Sangiovanni A, Santoro A, Trevisani F, Cisnero Garza LE, Gane E, O'Donnell A, Leon J, Lozano A, Jassem J, Rydzewska G, Szawlowski A, Tomczak P, Badulescu F, Miron L, Kubyshkin V, Bruix J, Forner A, Bustamante Schneider J, Diago M, Montero Alvarez JL, Pascual S, Ruíz del Arbol L, Sangro B, Solá R, Tabernero J, Muellhaupt B, Roth A, Jeffry Evans TR, Falk S, Meyer T, Reeves H, Ross P, Befeler A, Boyer T, Britten C, Byrne T, Garcia-Tsao G, Gold P, Goldenberg A, Heuman D, Kennedy P, Koch A, Llovet JM, Marrero J, Schilsky M, Schwartz J, Schwartz M
      Clin. Cancer Res., 2012;18(8):2290-300.
      Species: Human
      Sample Type: Plasma
    3. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans.
      Authors: Schirmer SH, van Royen N, Moerland PD, Fledderus JO, Henriques JP, van der Schaaf RJ, Vis MM, Baan J, Koch KT, Horrevoets AJ, Hoefer IE, Piek JJ
      J. Am. Coll. Cardiol., 2009;53(23):2141-7.
      Species: Human
      Sample Type: Plasma
    4. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates.
      Authors: Kanter J, Khan SY, Kelher M, Gore L, Silliman CC
      Clin. Cancer Res., 2008;14(12):3942-7.
      Species: Human
      Sample Type: Platelet-Poor Plasma
    5. Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.
      Authors: Wedgwood S, Devol JM, Grobe A, Benavidez E, Azakie A, Fineman JR, Black SM
      Pediatr. Res., 2007;61(1):32-6.
      Species: Ovine
      Sample Type: Serum
    6. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
      Authors: Anagnostopoulos A, Eleftherakis-Papaiakovou V, Kastritis E, Tsionos K, Bamias A, Meletis J, Dimopoulos MA, Terpos E
      Br. J. Haematol., 2007;137(6):560-8.
      Species: Human
      Sample Type: Serum
    7. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
      Authors: Schneider P, Vasse M, Corbiere C, Legrand E, Marie-Cardine A, Boquet C, Cazin L, Vannier JP
      Leuk. Res., 2007;31(5):629-38.
      Species: Human
      Sample Type: Plasma
    8. Dedicated epithelial recipient cells determine pigmentation patterns.
      Authors: Weiner L, Han R, Scicchitano BM, Li J, Hasegawa K, Grossi M, Lee D, Brissette JL
      Cell, 2007;130(5):932-42.
      Species: Mouse
      Sample Type: Cell Culture Supernates
    9. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
      Authors: Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS
      J. Clin. Oncol., 2006;24(22):3555-61.
      Species: Human
      Sample Type: Urine
    10. Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis.
      Authors: Bourlev V, Larsson A, Olovsson M
      Am. J. Obstet. Gynecol., 2006;194(3):755-9.
      Species: Human
      Sample Type: Peritoneal Fluid
    11. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.
      Authors: Mross K, Drevs J, Muller M, Medinger M, Marme D, Hennig J, Morgan B, Lebwohl D, Masson E, Ho YY, Gunther C, Laurent D, Unger C
      Eur. J. Cancer, 2005;41(9):1291-9.
      Species: Human
      Sample Type: Plasma
    12. Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release.
      Authors: Lacoste E, Martineau I, Gagnon G
      J. Periodontol., 2003;74(10):1498-507.
      Species: Human
      Sample Type: Cell Culture Supernates
    13. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
      Authors: Huang SF, Kim SJ, Lee AT, Karashima T, Bucana C, Kedar D, Sweeney P, Mian B, Fan D, Shepherd D, Fidler IJ, Dinney CP, Killion JJ
      Cancer Res., 2002;62(20):5720-6.
      Species: Mouse
      Sample Type: Serum
    14. Targeted disruption of fibroblast growth factor receptor-1 blocks maturation of visceral endoderm and cavitation in mouse embryoid bodies.
      Authors: Esner M, Pachernik J, Hampl A, Dvorak P
      Int. J. Dev. Biol., 2002;46(6):817-25.
      Species: Bovine
      Sample Type: Serum
    15. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.
      Authors: Allen DK, Waters DJ, Knapp DW, Kuczek T
      J. Vet. Intern. Med., 1996;10(4):231-4.
      Species: Canine
      Sample Type: Whole Cells
    16. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.
      Authors: Allen DK, Waters DJ, Knapp DW, Kuczek T
      J. Vet. Intern. Med., 1996;10(4):231-4.
      Species: Canine
      Sample Type: Urine
    Expand to show all

    Have you used Human FGF basic Quantikine HS ELISA Kit?

    Submit a review and receive a $25 amazon gift card if you include an image - $10 Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

    Order Details

    Contact Information

    Certificate of Analysis Lookup

    The document you requested is not available online. Please enter the Catalog Number and Lot Number below to have a document emailed to you at the address provided

    Certificate of Analysis Lookup

    Research Areas of Interest
    R&D Systems Guarantee


    Customer Information